Poster

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Discover how active learning and Bayesian optimization improve virtual population generation for quantitative systems pharmacology…

Certara2026 年 6 月 18 日

Poster

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Discover how a mechanistic quantitative systems pharmacology (QSP) model predicts mast cell inhibition and depletion…

Certara2026 年 6 月 16 日

Webinar

Building IND-Ready and Investor-Ready Development Programs

Certara2026 年 6 月 15 日

Announcement

Certara 再次中标欧洲药品管理局合同，进一步拓展了在塑造监管决策中真实世界证据未来方面的机遇

Certara was reappointed to a 4 year EMA and ECDC framework contract to generate real-world…

Certara2026 年 6 月 11 日

Poster

Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study

Download this poster to see how Certara used quantitative systems pharmacology (QSP) to translate ¹⁷⁷Lu-PSMA-617…

Certara2026 年 6 月 9 日

Poster

Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies

Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.

Certara2026 年 6 月 9 日

Blog

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

Explore how ICH M15 is shaping regulatory expectations for Model-Informed Drug Development (MIDD), including model…

Certara2026 年 6 月 9 日

Press Coverage

支持模拟孕妇用药剂量的理由

孕妇通常被排除在药物临床试验之外，这使得临床医生缺乏用药剂量的指导。Discover how…

Certara2026 年 6 月 9 日

Case Study

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

Certara’s drug development support enabled a positive scientific opinion from the EMA for acoziborole, a…

Certara2026 年 6 月 2 日

Webinar

Model Acceptance in Regulatory Submissions: Practical Strategies for Regulatory Success

Certara2026 年 6 月 1 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Certara 服务

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Building IND-Ready and Investor-Ready Development Programs

Certara 再次中标欧洲药品管理局合同，进一步拓展了在塑造监管决策中真实世界证据未来方面的机遇

Translating Targeted Radiotherapies from Mouse to Human Using QSP: A Pluvicto Case Study

Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

支持模拟孕妇用药剂量的理由

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

Model Acceptance in Regulatory Submissions: Practical Strategies for Regulatory Success

订阅时事通讯

快捷链接

解决方案

联系我们